psilocybin
-
healthPsychedelics: A New Frontier in Mental Health Treatment
Psychedelic-assisted therapies show promise for treatment-resistant mental illness, with psilocybin leading trials as a potential FDA-approved treatment.
-
healthSingle Psilocybin Dose Reshapes Brain Function and Anatomy
A 2026 study found that a single 25 mg dose of psilocybin induces measurable brain changes for up to a month, boosting entropy and altering white matter.
-
healthPsilocybin’s Lasting Brain Rewiring: A Single Dose Linked to Month-Long Well-Being
New study shows a single 25mg psilocybin dose can 'loosen' brain patterns, improving mental well-being for up to a month via increased brain entropy.
-
healthTrump Accelerates Research on Psychedelic Drugs for Mental Health
President Trump signs an executive order to fast-track research into psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, particularly in veterans.
-
healthVeteran Leads Psilocybin Retreats for PTSD Ahead of FDA Approval
Army veteran Jesse Gould offers psilocybin retreats for PTSD, aiming to provide an alternative to lifelong medication while states explore therapeutic legalization.
-
healthPsychedelics Share Common Brain 'Fingerprint,' Study Reveals
A groundbreaking study identifies a shared neural signature across five psychedelics, offering new insights into their therapeutic potential for mental health disorders.
-
healthScientists Engineer Tobacco Plant to Produce 5 Psychedelic Compounds Simultaneously
Researchers at the Weizmann Institute have engineered a tobacco plant to produce five psychedelic compounds, offering a new avenue for therapeutic research and production.